Condition:   Psoriatic Arthritis
Interventions:   Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo;   Drug: Placebo
Sponsors:   Pfizer;   Pfizer
Not yet recruiting - verified September 2013